Pneumonia
📧 Sign up to get email alerts when something new happens for Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001) [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating the polyvalent pneumococcal conjugate vaccine V116 in adults has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine [Phase 4]
A Phase 4 trial update on combining quadrivalent influenza vaccine with the 23-valent pneumococcal polysaccharide vaccine for influenza and …
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE) [Phase 2]
Phase 2 clinical trial Update for M5049 in participants with COVID-19 pneumonia (ANEMONE) has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 [Phase 1, Phase 2]
Clinical trial update for CYNK-001 natural killer cell infusions in adults with COVID-19, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Evaluation of a Disposable Flexible Bronchoscope, aScope IV [NA]
Clinical trial update for a disposable flexible bronchoscope (aScope IV) has been terminated; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants [Phase 3]
Phase 3 trial of Pneumosil given in a 2+1 schedule to healthy infants; completed with posted results in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. [Phase 1]
Phase 1 clinical trial update for COVID-19 convalescent plasma in hospitalized pneumonia due to SARS-CoV-2; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2022-04-01Clinical Trial Update: Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia [Phase 2]
Phase 2 trial update on convalescent plasma for treating COVID-19 pneumonia; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia [Phase 2]
Phase 2 trial evaluating safety and efficacy of XAV-19 in patients with COVID-19–related moderate pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Reparixin in COVID-19 Pneumonia - Efficacy and Safety [Phase 2, Phase 3]
Clinical trial update for Reparixin in severe pneumonia (COVID-19) shows termination with posted results; phases 2 and 3 were conducted but …
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Zinc Pneumonia Outpatient Trial in Children < 2 Years [Phase 3]
Phase 3 trial update for zinc treatment in outpatient children under 2 with pneumonia; study completed.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients [Phase 4]
Phase 4 trial evaluating recombinant human thrombopoietin for increasing platelet levels in ICU patients with pneumonia and thrombocytopenia…
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines [Phase 4]
Phase 4 clinical trial evaluating genomics and epigenomics of the elderly response to pneumococcal vaccines; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia [Phase 4]
Phase 4 pharmacokinetic and pharmacodynamic study evaluating intravenous linezolid in MRSA-positive, morbidly obese patients with pneumonia …
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME) [Phase 3]
Phase 3 trial update for OVERCOME evaluating treatment of extensively drug-resistant gram-negative infections; study completed with results …
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: The Place of Imaging and Microbiology in the Diagnosis of Pneumonia in the Elderly [NA]
A completed clinical trial evaluating the role of imaging and microbiology in diagnosing pneumonia in the elderly.
-
CLINICAL_TRIALS trial_result · 2021-10-13Clinical Trial Update: An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19 [Phase 3]
Phase 3 randomized trial evaluating the combination of Dalargin with Leitragin for severe and critical SARS-CoV-2 infections has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia [Phase 2]
Phase 2 trial update on steroid dosing guided by bio-marker titration in critically ill pneumonia patients; results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Nebulized Heparin for the Treatment of COVID-19 [Phase 4]
Phase 4 trial update investigating nebulized heparin for the treatment of COVID-19, with completed status.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: A Study of LY3127804 in Participants With COVID-19 [Phase 2]
Phase 2 clinical trial of LY3127804 in COVID-19 patients was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation [Phase 2]
Phase 2 clinical trial evaluating mavrilimumab to reduce progression of acute respiratory failure in COVID-19 pneumonia with systemic hyper-…
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) [Phase 2, Phase 3]
A clinical trial update on antithrombotic therapy to reduce complications in COVID-19, spanning Phase 2 and Phase 3, with completed status.
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19 [Phase 1, Phase 2]
Phase 1/2 clinical trial of inhalation low-dose radionuclide therapy for COVID-19 and related pneumonia completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Yinhu Qingwen Granula for the Treatment of Severe CoVID-19 [Phase 2, Phase 3]
Clinical trial update for Yinhu Qingwen Granula in treating severe COVID-19 has suspended its Phase 2/Phase 3 studies.
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia [Phase 2]
Phase 2 clinical trial update evaluating FX06 to rescue acute respiratory distress syndrome in COVID-19 pneumonia.